/BCRX

BioCryst Pharmaceuticals Inc

BCRX

$8.12USD↓-2.05%-0.17 today

MARKET CAP

2.1B

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$8 – $8

52W RANGE

$6

$11

AI Summary

Stalk

StalkMedium

Despite a decisive support failure on elevated volume, extreme oversold conditions have triggered mean-reversion eligibility, flipping the medium-term bias to bullish. However, short-term execution remains unfavorable as price trades below declining 9/20/50 EMAs and rejects on minor rebounds. We will stalk for a pullback into structural support around the 200-day SMA and prior consolidation lows under the Growth at Reasonable Price strategy before considering a long entry.

↑Q2 revenue rose 45% YoY to $213.9M, driven by ORLADEYO demand.
↑Consensus price target of $20.60 implies 108% upside potential.
↓Negative earnings yield and low book-to-price point to premium valuation.

Full analysis →

Buying

11

institutions

Selling

8

institutions

New Positions

3

this quarter

Filing Period

Q1 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	23.89 M	238.93 M	+1.24 M	+10.8%	0.00%
JH Janus Henderson Group Plc Q1 2026	BUY	17.82 M	169.71 M	+10.41 M	+193.7%	0.04%
PA Perceptive Advisors LLC Q2 2026	SELL	10.31 M	103.09 M	+-4.56 M	-27.2%	1.55%
MM Millennium Management LLC Q2 2026	BUY	3.39 M	33.95 M	+3.08 M	+1022.3%	0.01%
FA Fisher Asset Management, LLC Q2 2026	SELL	2.60 M	26.04 M	+-129.23 K	+0.1%	0.01%
RT Renaissance Technologies LLC Q2 2026	BUY	2.53 M	25.30 M	+1.75 M	+242.1%	0.03%
AC Aqr Capital Management LLC Q2 2026	BUY	2.21 M	22.14 M	+1.77 M	+428.4%	0.01%
CA Citadel Advisors LLC Q2 2026	BUY	2.14 M	21.36 M	+921.41 K	+84.7%	0.00%
EP Eversept Partners, LP Q2 2026	SELL	1.87 M	18.66 M	+-1.17 M	-35.5%	0.97%
MC Moore Capital Management, LP Q2 2026	BUYNEW	848.34 K	8.48 M	+848.34 K	+0.0%	0.13%
MG Man Group Plc Q2 2026	SELL	732.87 K	7.33 M	+-560.43 K	-40.5%	0.01%
JC Jpmorgan Chase & Co Q2 2026	SELL	525.45 K	5.12 M	+-1.02 M	-64.8%	0.00%
BA Bridgewater Associates, LP Q2 2026	SELL	491.06 K	4.91 M	+-147.00 K	-19.2%	0.02%
PA Point72 Asset Management, L.P. Q2 2026	BUYNEW	260.92 K	2.61 M	+260.92 K	+0.0%	0.00%
HS Hussman Strategic Advisors, Inc. Q2 2026	BUYNEW	210.00 K	2.10 M	+210.00 K	+0.0%	0.48%
AC Adar1 Capital Management, LLC Q2 2026	BUY	133.00 K	1.33 M	+28.00 K	+33.0%	0.06%
BH Brevan Howard Capital Management LP Q2 2026	BUY	96.57 K	965.74 K	+77.69 K	+437.1%	0.01%
RC Rockefeller Capital Management L.P. Q2 2026	SELL	33.49 K	334.95 K	+-1.39 K	+0.9%	0.00%
BA Balyasny Asset Management L.P. Q2 2026	SELL	0.00	0.00	+-186.12 K	-100.0%	0.00%